Deficit Syndrome of Schizophrenia - Assuaging by Norepinephrine Reuptake Inhibitor
Saeed Shoja Shafti,
Mohammad Sadeghe Jafarabad and
Additional contact information
Saeed Shoja Shafti: Professor of Psychiatry, University of Social Welfare and Rehabilitation Sciences, Razi Psychiatric Hospital, Tehran, Iran
Mohammad Sadeghe Jafarabad: Psychiatrist, Razi Psychiatric Hospital, Iran
Reza Azizi: General physician, Razi Psychiatric Hospital, Iran
Biomedical Journal of Scientific & Technical Research, 2019, vol. 18, issue 3, 13631-13636
Despite advances made in treating the positive symptoms of schizophrenia, treatment of negative symptoms remains an unmet therapeutic need...
Keywords: Biomedical Sciences; Biomedical Research; Technical Research; Schizophrenia; Negative Symptom; Reboxetine (search for similar items in EconPapers)
JEL-codes: R00 Z0 (search for similar items in EconPapers)
References: View complete reference list from CitEc
Citations: Track citations by RSS feed
Downloads: (external link)
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
Persistent link: https://EconPapers.repec.org/RePEc:abf:journl:v:18:y:2019:i:3:p:13631-13636
Access Statistics for this article
Biomedical Journal of Scientific & Technical Research is currently edited by Robert Thomas
More articles in Biomedical Journal of Scientific & Technical Research from Biomedical Research Network+, LLC
Bibliographic data for series maintained by Angela Roy ().